atc_level_01_code,atc_level_01_name,atc_level_02_code,atc_level_02_name,atc_level_03_code,atc_level_03_name,atc_level_04_code,atc_level_04_name,atc_level_04_note,atc_level_05_code,atc_level_05_name,atc_level_05_note,DDD_N,DDD_O,DDD_P,DDD_SL,unit_N,unit_O,unit_P,unit_SL
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AA,ACTH,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of corticotrophin is based on therapy, whereas that of tetracosactide is based on use as a diagnostic agent.",H01AA01,corticotropin,NA,NA,NA,25,NA,NA,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AA,ACTH,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of corticotrophin is based on therapy, whereas that of tetracosactide is based on use as a diagnostic agent.",H01AA02,tetracosactide,NA,NA,NA,0.25,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AB,Thyrotropin,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD for biological thyrotropin classified in H01AB01 is 5 U.,H01AB01,thyrotropin alfa,NA,NA,NA,0.9,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC01,somatropin,NA,NA,NA,2,NA,NA,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC02,somatrem,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC03,mecasermin,NA,NA,NA,2,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC04,sermorelin,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC05,mecasermin rinfabate,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC06,tesamorelin,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC07,somapacitan,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC08,somatrogon,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of growth retardation in children with a body weight of 25 kg.,H01AC09,lonapegsomatropin,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AX,Other anterior pituitary lobe hormones and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01AX01,pegvisomant,NA,NA,NA,10,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of diabetes insipidus.The DDD for terlipressin (as acetate) is based on treatment of bleeding oesophageal varices.,H01BA01,vasopressin (argipressin),NA,NA,NA,40,NA,NA,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of diabetes insipidus.The DDD for terlipressin (as acetate) is based on treatment of bleeding oesophageal varices.,H01BA02,desmopressin,base,NA,NA,NA,0.24,NA,NA,NA,mg
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of diabetes insipidus.The DDD for terlipressin (as acetate) is based on treatment of bleeding oesophageal varices.,H01BA02,desmopressin,NA,25,0.4,4,NA,mcg,mg,mcg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of diabetes insipidus.The DDD for terlipressin (as acetate) is based on treatment of bleeding oesophageal varices.,H01BA03,lypressin,NA,20,NA,20,NA,U,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of diabetes insipidus.The DDD for terlipressin (as acetate) is based on treatment of bleeding oesophageal varices.,H01BA04,terlipressin,NA,NA,NA,12,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of diabetes insipidus.The DDD for terlipressin (as acetate) is based on treatment of bleeding oesophageal varices.,H01BA05,ornipressin,NA,NA,NA,5,NA,NA,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BB,Oxytocin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on use in delivery.,H01BB01,demoxytocin,NA,NA,100,NA,NA,NA,U,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BB,Oxytocin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on use in delivery.,H01BB02,oxytocin,NA,15,200,15,NA,U,U,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BB,Oxytocin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on use in delivery.,H01BB03,carbetocin,NA,NA,NA,0.1,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CA,Gonadotropin-releasing hormones,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of nafarelin is based on the treatment of endometriosis.  No other DDDs have been assigned, due to the highly variable dosages used.",H01CA01,gonadorelin,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CA,Gonadotropin-releasing hormones,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of nafarelin is based on the treatment of endometriosis.  No other DDDs have been assigned, due to the highly variable dosages used.",H01CA02,nafarelin,NA,0.4,NA,NA,NA,mg,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.,H01CB01,somatostatin,NA,NA,NA,6,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.,H01CB02,octreotide,NA,NA,NA,0.7,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.,H01CB03,lanreotide,NA,NA,NA,3,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.,H01CB04,vapreotide,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.,H01CB05,pasireotide,NA,NA,NA,1.2,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01CC01,ganirelix,NA,NA,NA,0.25,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01CC02,cetrorelix,NA,NA,NA,0.25,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01CC03,elagolix,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01CC04,linzagolix,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01CC53,"elagolix, estradiol and norethisterone",NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H01CC54,"relugolix, estradiol and norethisterone",NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AA,Mineralocorticoids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on substitution therapy in Addisons disease.,H02AA01,aldosterone,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AA,Mineralocorticoids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on substitution therapy in Addisons disease.,H02AA02,fludrocortisone,NA,NA,0.1,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AA,Mineralocorticoids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on substitution therapy in Addisons disease.,H02AA03,desoxycortone,NA,NA,5,5,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB01,betamethasone,depot,NA,NA,0.4,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB01,betamethasone,NA,NA,1.5,1.5,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB02,dexamethasone,NA,NA,1.5,1.5,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB03,fluocortolone,NA,NA,10,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB04,methylprednisolone,NA,NA,7.5,20,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB05,paramethasone,NA,NA,4,4,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB06,prednisolone,NA,NA,10,10,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB07,prednisone,NA,NA,10,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB08,triamcinolone,NA,NA,7.5,7.5,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB09,hydrocortisone,NA,NA,30,30,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB10,cortisone,NA,NA,37.5,37.5,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB11,prednylidene,NA,NA,12,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB12,rimexolone,intraarticular,NA,NA,20,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB13,deflazacort,NA,NA,15,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB14,cloprednol,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB15,meprednisone,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB17,cortivazol,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,Glucocorticoids,"The DDDs are generally based on the treatment or diagnosis of endocrine disorders. Depot preparations may have different DDDs, compared to other formulations, due to different indications.",H02AB18,vamorolone,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02B,"CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS",H02BX,"Corticosteroids for systemic use, combinations",The DDDs are generally based on the treatment or diagnosis of endocrine disorders. No DDDs have been assigned.,H02BX01,"methylprednisolone, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of trilostan is based on the treatment of Cushings syndrome.,H02CA01,trilostane,NA,NA,0.36,NA,NA,NA,g,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of trilostan is based on the treatment of Cushings syndrome.,H02CA02,osilodrostat,NA,NA,10,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of trilostan is based on the treatment of Cushings syndrome.,H02CA03,ketoconazole,NA,NA,0.6,NA,NA,NA,g,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of trilostan is based on the treatment of Cushings syndrome.,H02CA04,levoketoconazole,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hypothyrosis.,H03AA01,levothyroxine sodium,NA,NA,0.15,0.15,NA,NA,mg,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hypothyrosis.,H03AA02,liothyronine sodium,NA,NA,60,60,NA,NA,mcg,mcg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hypothyrosis.,H03AA03,combinations of levothyroxine and liothyronine,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hypothyrosis.,H03AA04,tiratricol,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hypothyrosis.,H03AA05,thyroid gland preparations,NA,NA,0.1,NA,NA,NA,g,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hypothyrosis.,H03AA51,levothyroxine sodium and iodine compounds,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BA,Thiouracils,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BA01,methylthiouracil,NA,NA,0.1,NA,NA,NA,g,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BA,Thiouracils,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BA02,propylthiouracil,NA,NA,0.1,NA,NA,NA,g,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BA,Thiouracils,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BA03,benzylthiouracil,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BB,Sulfur-containing imidazole derivatives,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BB01,carbimazole,NA,NA,15,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BB,Sulfur-containing imidazole derivatives,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BB02,thiamazole,NA,NA,10,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BB,Sulfur-containing imidazole derivatives,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BB52,"thiamazole, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BC,Perchlorates,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BC01,potassium perchlorate,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BX,Other antithyroid preparations,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BX01,diiodotyrosine,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03B,ANTITHYROID PREPARATIONS,H03BX,Other antithyroid preparations,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs are based on the treatment of hyperthyrosis.,H03BX02,dibromotyrosine,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY,H03C,IODINE THERAPY,H03CA,Iodine therapy,NA,H03CA,Iodine therapy,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H04,PANCREATIC HORMONES,H04A,GLYCOGENOLYTIC HORMONES,H04AA,Glycogenolytic hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of glucagon is based on single dose treatment of hypoglycemia.,H04AA01,glucagon,NA,3,NA,1,NA,mg,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H04,PANCREATIC HORMONES,H04A,GLYCOGENOLYTIC HORMONES,H04AA,Glycogenolytic hormones,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDD of glucagon is based on single dose treatment of hypoglycemia.,H04AA02,dasiglucagon,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H05AA01,parathyroid gland extract,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H05AA02,teriparatide,NA,NA,NA,20,NA,NA,NA,mcg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H05AA03,parathyroid hormone,NA,NA,NA,0.1,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H05AA04,abaloparatide,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,The DDDs are generally based on the treatment or diagnosis of endocrine disorders.,H05AA05,palopegteriparatide,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of the calcitonins are based on the treatment of Pagets disease.,H05BA01,calcitonin (salmon synthetic),NA,200,NA,100,NA,U,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of the calcitonins are based on the treatment of Pagets disease.,H05BA02,calcitonin (pork natural),NA,NA,NA,100,NA,NA,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of the calcitonins are based on the treatment of Pagets disease.,H05BA03,calcitonin (human synthetic),NA,NA,NA,100,NA,NA,NA,U,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs of the calcitonins are based on the treatment of Pagets disease.,H05BA04,elcatonin,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs for cinacalcet and evocalcet are based on the treatment of secondary hyperparathyroidism.,H05BX01,cinacalcet,NA,NA,60,NA,NA,NA,mg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs for cinacalcet and evocalcet are based on the treatment of secondary hyperparathyroidism.,H05BX02,paricalcitol,NA,NA,2,2,NA,NA,mcg,mcg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs for cinacalcet and evocalcet are based on the treatment of secondary hyperparathyroidism.,H05BX03,doxercalciferol,NA,NA,NA,NA,NA,NA,NA,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs for cinacalcet and evocalcet are based on the treatment of secondary hyperparathyroidism.,H05BX04,etelcalcetide,NA,NA,NA,2.1,NA,NA,NA,mg,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs for cinacalcet and evocalcet are based on the treatment of secondary hyperparathyroidism.,H05BX05,calcifediol,NA,NA,30,NA,NA,NA,mcg,NA,NA
H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents,The DDDs are generally based on the treatment or diagnosis of endocrine disorders. The DDDs for cinacalcet and evocalcet are based on the treatment of secondary hyperparathyroidism.,H05BX06,evocalcet,NA,NA,2.5,NA,NA,NA,mg,NA,NA
